SK279393B6 - Estery kyseliny bisfenylpiperazínnikotínovej, spôs - Google Patents

Estery kyseliny bisfenylpiperazínnikotínovej, spôs Download PDF

Info

Publication number
SK279393B6
SK279393B6 SK1585-94A SK158594A SK279393B6 SK 279393 B6 SK279393 B6 SK 279393B6 SK 158594 A SK158594 A SK 158594A SK 279393 B6 SK279393 B6 SK 279393B6
Authority
SK
Slovakia
Prior art keywords
formula
nicotinic acid
bisphenylpiperazine
group
acid ester
Prior art date
Application number
SK1585-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK158594A3 (en
Inventor
Torbjrn Lundstedt
Lisbeth Abramo
Anders Bj�Rk
G�Ran Pettersson
Gunnar Andersson
Curt Nordvi
Wu Jin Chang
Catarina Ludwig
Elisabeth Seifert
Arne Nilsson
Original Assignee
Pharmacia & Upjohn Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Aktiebolag filed Critical Pharmacia & Upjohn Aktiebolag
Publication of SK158594A3 publication Critical patent/SK158594A3/sk
Publication of SK279393B6 publication Critical patent/SK279393B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK1585-94A 1992-06-25 1993-06-23 Estery kyseliny bisfenylpiperazínnikotínovej, spôs SK279393B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (2)

Publication Number Publication Date
SK158594A3 SK158594A3 (en) 1995-07-11
SK279393B6 true SK279393B6 (sk) 1998-11-04

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1585-94A SK279393B6 (sk) 1992-06-25 1993-06-23 Estery kyseliny bisfenylpiperazínnikotínovej, spôs

Country Status (27)

Country Link
US (1) US5658910A (de)
EP (2) EP0673368B1 (de)
JP (1) JP3306827B2 (de)
KR (1) KR100302216B1 (de)
CN (1) CN1085981C (de)
AT (2) ATE209634T1 (de)
AU (1) AU681346B2 (de)
BG (1) BG62000B1 (de)
CA (1) CA2139112C (de)
CZ (1) CZ281975B6 (de)
DE (2) DE69333655D1 (de)
DK (1) DK0673368T3 (de)
EE (1) EE03122B1 (de)
ES (1) ES2169044T3 (de)
FI (1) FI107151B (de)
HU (2) HU220613B1 (de)
IL (1) IL106135A (de)
NO (1) NO302945B1 (de)
NZ (1) NZ253823A (de)
PH (1) PH31417A (de)
PT (1) PT673368E (de)
RO (1) RO115725B1 (de)
RU (1) RU2127732C1 (de)
SE (1) SE9201956D0 (de)
SK (1) SK279393B6 (de)
WO (1) WO1994000434A1 (de)
ZA (1) ZA934596B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
DE69919707T2 (de) 1998-06-19 2005-09-01 Chiron Corp., Emeryville Glycogen synthase kinase 3 inhibitoren
IL278435B2 (en) * 2018-05-09 2024-06-01 Lg Chemical Ltd A new compound showing enteropeptidase inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
DE69333655D1 (de) 2004-11-11
KR100302216B1 (ko) 2001-11-22
ES2169044T3 (es) 2002-07-01
DK0673368T3 (da) 2002-03-18
RO115725B1 (ro) 2000-05-30
BG62000B1 (bg) 1998-12-30
BG99289A (bg) 1995-09-29
NO302945B1 (no) 1998-05-11
FI946085A0 (fi) 1994-12-23
EP0673368B1 (de) 2001-11-28
IL106135A (en) 1999-01-26
CZ327494A3 (en) 1995-09-13
PH31417A (en) 1998-10-29
ATE209634T1 (de) 2001-12-15
EP1120410A1 (de) 2001-08-01
DE69331234D1 (de) 2002-01-10
ZA934596B (en) 1994-02-14
EP0673368A1 (de) 1995-09-27
CA2139112C (en) 2006-03-21
NO945022L (no) 1995-02-13
HU9403786D0 (en) 1995-02-28
DE69331234T2 (de) 2002-08-08
HU220613B1 (hu) 2002-03-28
FI946085A (fi) 1994-12-23
EP1120410B1 (de) 2004-10-06
AU4519393A (en) 1994-01-24
PT673368E (pt) 2002-05-31
HU210875A9 (en) 1995-08-28
WO1994000434A1 (en) 1994-01-06
CN1086811A (zh) 1994-05-18
HUT71406A (en) 1995-11-28
CA2139112A1 (en) 1994-01-06
CN1085981C (zh) 2002-06-05
ATE278671T1 (de) 2004-10-15
KR950702186A (ko) 1995-06-19
RU2127732C1 (ru) 1999-03-20
JPH07508517A (ja) 1995-09-21
RU94046310A (ru) 1996-10-27
NO945022D0 (no) 1994-12-23
AU681346B2 (en) 1997-08-28
EE03122B1 (et) 1998-10-15
JP3306827B2 (ja) 2002-07-24
IL106135A0 (en) 1993-10-20
SK158594A3 (en) 1995-07-11
SE9201956D0 (sv) 1992-06-25
US5658910A (en) 1997-08-19
CZ281975B6 (cs) 1997-04-16
FI107151B (fi) 2001-06-15
NZ253823A (en) 1996-01-26

Similar Documents

Publication Publication Date Title
US5589477A (en) Pyrimidine derivatives and drugs
CS258119B2 (en) Method of 1-heteroaryl-4(2,5-pyrrolidione-1-yl)alkyl)piperazine derivatives production
KR0155543B1 (ko) 1-[모노-또는 비스(트리플루오로메틸)-2-피리디닐]피페라진을 함유한 약학조성물
WO1996034856A1 (en) 2-ureido-benzamide derivatives
US5135931A (en) Pyridinylpiperazine derivatives
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
HU203232B (en) Process for producing new pyridyl and pyrimidinyl derivatives
SK279393B6 (sk) Estery kyseliny bisfenylpiperazínnikotínovej, spôs
JPH06234762A (ja) ２−［４−（４−アゾリルブチル）−１−ピペラジニル］−５−ヒドロキシピリミジン誘導体
EP0652867B1 (de) Neue pyridyl-und pyrimidylpiperazin-derivate
NL8100998A (nl) Piperazinederivaat.
GB2162843A (en) Piperazine derivatives
KR100226328B1 (ko) 4-(4-또는6-(트리플루오로메틸-2-피리디닐))-1-피페라지닐알킬치환된락탐
US5439940A (en) Benz[e]indene derivatives
JPH04352721A (ja) 神経成長因子産生促進作用剤
NO179409B (no) Psykoaktive 4-[4-eller 6-(trifluormetyl-2-pyridinyl)Å-1-piperazinyl-alkylsubstituerte laktamer og anvendelse derav

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100623